Alexandria Pharmaceuticals OGM adopts FY17/18 budget

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries said Sunday that its ordinary general meeting (OGM) has approved the estimated budget and investment plan for fiscal year 2017/2018.

The company targets an increase of 28.6% in profits for FY17/18, and set the investment budget for the year at EGP 10.3 million, according to a bourse filing.

Mubasher Contribution Time: 26-Mar-2017 09:23 (GMT)
Mubasher Last Update Time: 26-Mar-2017 09:28 (GMT)